ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

Last updated:

Basilea - About the company

Basilea is a public company based in Basel (Switzerland), founded in 1999. It operates as a Developer of antibiotics, antifungals, and oncology drugs for treating multiple diseases. Basilea has raised an undisclosed amount in funding. The company has 127 active competitors, including 41 funded and 22 that have exited. Its top competitors include companies like Insmed, Evofem and Affinivax.

Company Details

Developer of antibiotics, antifungals, and oncology drugs for treating multiple diseases. Its product portfolio includes ceftobiprole for pneumonia, isavuconazole for fungal infections, and 3 other pipeline products under development. It also has a leading candidate BAL 101553 for recurrent or progressive glioblastoma.
Website
Email ID
@basilea.com
Key Metrics
Founded Year
1999
Location
Basel, Switzerland
Stage
Public
Latest Funding Round
Investors
Ranked
Similar Companies
Exit Details
Public

Legal entities associated with Basilea

Basilea is associated with 1 legal entity given below:
Legal Entity Name
Date of incorporation
Revenue
Net Profit
Employee Count
Jul 09, 2007
-
347
259
Get your free copy of Basilea's company profile

Basilea's funding and investors

Basilea has raised funding over 7 rounds. Its first funding round was on 2001. Its latest funding round was a Grant (prize money) round on Dec 23, 2024 for $7.3M. 1 investor participated in its latest round, which include Athyrium Capital Management, HBM Partners and CARB-X.

Basilea has 3 institutional investors including , HBM Partners and CARB-X.

Here is the list of recent funding rounds of Basilea:
Date of funding
Funding Amount
Round Name
Post money valuation
Revenue multiple
Investors
Dec 23, 2024
$7.3M
Grant (prize money)
2536664
8509195
Apr 09, 2024
$900K
Grant (prize money)
2725073
5794472
Aug 16, 2021
$4.3M
Grant (prize money)
9338081
5140835
-
lockAccess funding benchmarks and valuations. Sign up today!

Basilea's Competitors and alternates

Top competitors of Basilea include Insmed, Evofem and Affinivax. Here is the list of Top 10 competitors of Basilea, ranked by ÃØÃÜÑо¿Ëù score :
Overall Rank
Company Details
Short Description
Total Funding
Investors
ÃØÃÜÑо¿Ëù Score
1st
Logo for Insmed
Insmed
1999, Bridgewater (United States), Public
Developer of small molecule inhibitors for rare lung diseases
-
69/100
2nd
Logo for Evofem
Evofem
2009, San Diego (United States), Acquired
Developer of therapeutics for reproductive care for women
$100M
67/100
3rd
Logo for Affinivax
Affinivax
2013, Cambridge (United States), Acquired
Developer of technology-based conjugate vaccines against infectious diseases
$359M
Foresite Capital, T. Rowe PriceÌý&²¹³¾±è;Ìý
66/100
4th
Logo for Imvax
Imvax
2015, Philadelphia (United States), Series C
Developer of cell vaccines for the treatment of gliomas
$204M
Invus, MagnetarÌý&²¹³¾±è;Ìý
65/100
5th
Logo for Eligo Bioscience
Eligo Bioscience
2014, Paris (France), Series B
Developer of microbiome gene therapies against infectious disease
$52.3M
Seventure Partners, Khosla VenturesÌý&²¹³¾±è;Ìý
64/100
6th
Logo for Aridis Pharma
Aridis Pharma
2005, San Jose (United States), Public
Provider of human monoclonal antibodies against infectious diseases
$42.1M
, HHSÌý&²¹³¾±è;Ìý
63/100
7th
Logo for GT Medical Technologies
GT Medical Technologies
2017, Tempe (United States), Series C
Provider of medical devices for radiation therapy for bran tumor treatment
$116M
Gilde Healthcare, HorizonÌý&²¹³¾±è;Ìý
62/100
8th
Logo for Basilea
1999, Basel (Switzerland), Public
Developer of antibiotics, antifungals, and oncology drugs for treating multiple diseases
-
52/100
9th
Logo for MaaT Pharma
MaaT Pharma
2014, Lyon (France), Public
Developer of microbiome therapy for the treatment of intestinal dysbiosis diseases
$42.3M
60/100
10th
Logo for Lodo Therapeutics
Lodo Therapeutics
2015, New York City (United States), Acquired
Developer novel therapeutics to treat resistant infectious diseases and cancers using AI
$19.9M
58/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Basilea's competitors? Click to see the top ones

Basilea's Investments and acquisitions

Basilea has made no investments or acquisitions yet.

Reports related to Basilea

Here is the latest report on Basilea's sector:
View

News related to Basilea

Media has covered Basilea for a total of 29 events in the last 1 year, 16 of them have been about company updates and 3 about partnerships.
•
EuropaWire•Apr 24, 2025•Basilea,
•
GlobeNewswire•Apr 24, 2025•Basilea, Asahi Kasei
•
GlobeNewswire•Apr 16, 2025•Basilea
•
GlobeNewswire•Mar 14, 2025•Basilea, Pfizer
•
GlobeNewswire•Mar 14, 2025•Basilea
•
Seeking Alpha•Feb 18, 2025•Basilea
•
GlobeNewswire•Feb 18, 2025•Basilea
•
DJIB XINWEN•Feb 05, 2025•Basilea
•
EuropaWire•Feb 05, 2025•Basilea,
•
GlobeNewswire•Jan 28, 2025•Basilea
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

Frequently asked questions about Basilea

When was Basilea founded?
Basilea was founded in 1999.
Where is Basilea located?
Basilea is located in Basel, Switzerland.
When was the latest funding round of Basilea?
Basilea's latest funding round was on Dec 23, 2024.
What is the annual revenue of Basilea?
Annual revenue of Basilea is undefined as on undefined.
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
  • check icon 4M+ Companies
  • check icon 212K+ Investors
  • check icon 580K+ Funding Rounds
  • check icon 207K+ Acquisitions
  • check icon 2.9K+ Sectors
  • check icon 57K+ Business Models

Accel PartnersPartechIN-Q-TEL - USPalo Alto NetworkMaersk GrowthFujitsuTenityStanford
Are you a Founder ?
Explore our recently published companies
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long